MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fnagi.2018.00251

Медицинская библиотека · Frontiers in aging neuroscience · 2018

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer's Disease.

Huang Chun-Chao, Huang Wei-Ming, Chen Chia-Hung, Jhou Zong-Yi, The Alzheimer's Disease Neuroimaging Initiative, Lin Ching-Po

СтатьяПеревод пока не подготовлен

Аннотация

Introduction

This study aimed to survey the discrimination power of parameters from cerebrospinal fluid (CSF) biomarkers, fluorodeoxyglucose uptake on PET (FDG-PET), structural magnetic resonance imaging (MRI), and functional MRI in high- and low-risk subjects or in converters and stable subjects of normal and mild cognitive impairment (MCI) statuses.

Methods

We used baseline resting-state functional MRI (rfMRI) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset to analyze functional networks and recorded subjects' characteristics and results of the CSF study, FDG-PET, and structural MRI from the ADNI website. All parameters were evaluated based on the between-group difference among normal (NC), MCI, and Alzheimer's disease (AD) groups. The parameters other than CSF results were included to study the difference between high- and low-AD-risk subjects in NC or MCI groups, based on CSF results. On the basis of two-year follow-up conditions, all parameters were compared between stable subjects and converters in NC and MCI.

Results

CSF biomarkers, FDG-PET, structural MRI, and functional MRI are all able to differentiate AD from MCI or NC but not between MCI and NC. As compared with low-AD-risk subjects, high-risk subjects present decreased FDG-PET in both MCI and NC groups but structural MRI change only in MCI status and rfMRI alteration only in NC status. As compared with stable subjects, converters have decreased FDG-PET, functional network changes, and structural changes in both MCI and NC groups.

Conclusion

The combination of functional and structural MRI is a safer screening tool but with similar power as FDG-PET to reflect CSF change in the AD pathological process and to identify high-risk subjects and converters in NC and MCI.

Для цитирования: Huang Chun-Chao, Huang Wei-Ming, Chen Chia-Hung, Jhou Zong-Yi, The Alzheimer's Disease Neuroimaging Initiative, Lin Ching-Po. The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer's Disease.. Frontiers in aging neuroscience. 2018. DOI: 10.3389/fnagi.2018.00251.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.